1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Means/medians of brain volume measurements for CMV-infected and control groupsa
Volume (mL) CMV-Infected Fetuses (n = 42) Control Fetuses (n = 50) P STV 184.7 (24.2) 200.9 (32.6) .008b RHV 93.2 (11.8) 100.2 (17.1) .022b LHV 92.4 (12.5) 99.5 (17.1) .02b CV 9.5 (1.7) 10.3 (2.2) .084 REBV 1.58 (1.46–1.79) 1.82 (1.66–1.92) <.001b LEBV 1.61 (1.47–1.76) 1.79 (1.71–1.96) <.001b